Pregnant Women In Clinical Trials: US FDA Lays Out Different Considerations For Premarket, Postmarket

Draft guidance emphasizes postmarket consideration of other data, while advice on premarket trials suggests weighing 'prospect of direct benefit to the pregnant woman and/or fetus.'